Something old, something new: is praziquantel enough for schistosomiasis control?
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Something old, something new: is praziquantel enough for schistosomiasis control?
Authors
Keywords
-
Journal
Future Medicinal Chemistry
Volume 7, Issue 6, Pages 681-684
Publisher
Future Science, LTD
Online
2015-05-21
DOI
10.4155/fmc.15.9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Activity of Praziquantel Enantiomers and Main Metabolites against Schistosoma mansoni
- (2014) Isabel Meister et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- New praziquantel derivatives containing NO-donor furoxans and related furazans as active agents against Schistosoma mansoni
- (2014) Stefano Guglielmo et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- The little we know about the pharmacokinetics and pharmacodynamics of praziquantel (racemate and R-enantiomer)
- (2014) P. Olliaro et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Can Mass Drug Administration Lead to the Sustainable Control of Schistosomiasis?
- (2014) Allen G. P. Ross et al. JOURNAL OF INFECTIOUS DISEASES
- Once a year school-based deworming with praziquantel and albendazole combination may not be adequate for control of urogenital schistosomiasis and hookworm infection in Matuga District, Kwale County, Kenya
- (2014) Sammy M Njenga et al. Parasites & Vectors
- Evaluating the potential impact of mass praziquantel administration for HIV prevention in Schistosoma haematobium high-risk communities
- (2014) Martial L. Ndeffo Mbah et al. Epidemics
- Water-based interventions for schistosomiasis control
- (2014) William. Evan Secor Pathogens and Global Health
- Impact of Schistosoma mansoni on Malaria Transmission in Sub-Saharan Africa
- (2014) Martial L. Ndeffo Mbah et al. PLoS Neglected Tropical Diseases
- No Apparent Reduction in Schistosome Burden or Genetic Diversity Following Four Years of School-Based Mass Drug Administration in Mwea, Central Kenya, a Heavy Transmission Area
- (2014) Agola E. Lelo et al. PLoS Neglected Tropical Diseases
- Praziquantel, Mefloquine-Praziquantel, and Mefloquine-Artesunate-Praziquantel against Schistosoma haematobium: A Randomized, Exploratory, Open-Label Trial
- (2014) Jennifer Keiser et al. PLoS Neglected Tropical Diseases
- Assessment of Quality of Life as a Tool for Measuring Morbidity Due to Schistosoma mansoni Infection and the Impact of Treatment
- (2013) Kimberly Y. Won et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Genetic and Molecular Basis of Drug Resistance and Species-Specific Drug Action in Schistosome Parasites
- (2013) C. L. L. Valentim et al. SCIENCE
- Comparative efficacy of one versus two doses of praziquantel on cure rate of Schistosoma mansoni infection and re-infection in Mayuge District, Uganda
- (2013) Edridah M. Tukahebwa et al. TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
- Time to set the agenda for schistosomiasis elimination
- (2012) David Rollinson et al. ACTA TROPICA
- Efficacy and safety of two closely spaced doses of praziquantel against Schistosoma haematobium and S. mansoni and re-infection patterns in school-aged children in Niger
- (2012) Amadou Garba et al. ACTA TROPICA
- Community Health Workers' Experiences and Perspectives on Mass Drug Administration for Schistosomiasis Control in Western Kenya: The SCORE Project
- (2012) Martin O. Omedo et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Study and implementation of urogenital schistosomiasis elimination in Zanzibar (Unguja and Pemba islands) using an integrated multidisciplinary approach
- (2012) Stefanie Knopp et al. BMC PUBLIC HEALTH
- Utility of Repeated Praziquantel Dosing in the Treatment of Schistosomiasis in High-Risk Communities in Africa: A Systematic Review
- (2011) Charles H. King et al. PLoS Neglected Tropical Diseases
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More